tirzepatide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42244136
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
- 저자
- Wajd Alkabbani, Salvatore Crisafulli, Julie M Paik, Ali Tavakkoli, Katsiaryna Bykov, Robert J Glynn
- 저널
- Diabetes, obesity & metabolism
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.1111/dom.70963
문헌 요약
Evidence showing the association between glucagon-like 1 (GLP-1) based therapies and severe gastrointestinal motility events is limited and possible treatment effect heterogeneity by demographic and clinical characteristics is unknown. We aimed to compare rates of severe motility-related gastrointestinal adverse events between initiators of GLP-1 based th…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.